Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids

This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half of participants will receive corticosteroids alone, while the other half will receive corticosteroids with biliary stent at the beginning.

Inclusion Criteria:

• adults greater than 18 years-old;
• autoimmune pancreatitis and/or IgG4-related sclerosing cholangitis;
• obstructive jaundice

Exclusion Criteria:

• malignancies; active infections;
• pregnancy or breast feeding;
• standard contraindications to ERCP;
• unwillingness or inability to consent for the study